Andrea Santagati
University of Catania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andrea Santagati.
Farmaco | 2001
Annamaria Panico; Venera Cardile; Andrea Santagati; Barbara Gentile
The effects of a series of thienopyrimidine derivatives on the prevention of cartilage destruction in articular disease were investigated. Anti-degenerative activity was assayed on culture of nasal pig cartilage in the presence or in the absence of interleukin 1beta (IL-1beta). The amount of glycosaminoglycans (GAGs) and the production of nitric oxide (NO) in the culture medium were determined. Some thienopyrimidine derivatives, in the presence of IL-beta, blocked the cartilage breakdown by inhibiting both the NO production and GAGs release in a dose-dependent manner.
Bioorganic & Medicinal Chemistry Letters | 1996
Salvatore Guccione; Maria N. Modica; Jeanette Longmore; David Shaw; Gloria Uccello Barretta; Andrea Santagati; Maria Santagati; Filippo Russo
Abstract 1,6-Diphenyl-pyrazolo[3,4-d]thiazolo[3,2-a]4H-pyrimidin-4-one caused parallel displacement of the dose-response curve to the NK-2 receptor agonist in the guinea pig trachea suggesting it acts as a competitive antagonist. It is not active in the NK-1 and NK-3 receptor binding assays. A Ca ++ channel blocking action at the voltage-operated channels (L-type) was observed.
European Journal of Medicinal Chemistry | 1998
Andrea Santagati; J Longmore; Salvatore Guccione; Thierry Langer; E Tonnel; Maria N. Modica; Maria Santagati; L. Monsù Scolaro; Filippo Russo
Summary The pyrazolopyrimidothiazole ring system (compound N, table II) has been previously reported by us as a new competitive antagonist (apparent pA 2 = 7.3 equiv to 55 nM) at NK2-receptors. As part of our investigation on polycondensed heterocycles containing the pyrimidine ring as antagonists of G-protein coupled receptors, pyrimidoindole derivatives were prepared and tested in order to probe the topography of the NK2-receptors and ascertain the pattern of frameworks that result in optimum affinity and specificity. The title indole derivatives 5, 11a-d, 12c, 13a,b and 14b were ‘de novo’ designed or selected from our chemical archives and prepared by up-to-date synthetic routes, thus exploring new synthetic methodologies. According to the established graphic computer model, none of the tested substances exhibited activity as a consequence of the violation of an excluded volume area due the unfavourable position of the aromatic substituents.
Heterocycles | 1993
Andrea Santagati; Maria Santagati; Maria N. Modica
A versatile compound, 2,3,5,6,7,8-hexahydro-3-amino-2-thioxo[1]benzothienol[2,3-d]pyrimidin-4(1H)-one (4), was synthesized from ethyl 4,5,6,7-tetrahydro-2-isothiocyanato-1-benzothiophene-3-carboxylate(1). Derivatives of a heterocyclic linear system having the 1,3,4- thiadiazine ring were obtained from the key intermediate (4)
European Journal of Medicinal Chemistry | 1989
Filippo Russo; Andrea Santagati; Maria Santagati; A. Caruso; Maria Grazia Leone; Antonio Felice; Matilde Amico-Roxas
Abstract During our research on analgesic and anti-inflammatory active condensed heterocyclic compounds containing the pyrimidine ring, a number of thiazolothienopyrimidines was synthesized and tested. The results of pharmacological assays are reported and discussed.
Bioorganic & Medicinal Chemistry Letters | 2000
Maria N. Modica; Maria Santagati; Andrea Santagati; Filippo Russo; Alfredo Cagnotto; Mara Goegan; Tiziana Mennini
This paper reports the synthesis and affinities on the 5-HT1A versus the alpha1A receptors of new arylpiperazinylalkylthiothienopyrimidine and thiadiazole derivatives 16-24. Arylpiperazines 16-23 show affinities values in the nanomolar range for the 5-HT1A receptor. The compound 16 is highly potent (Ki 0.26 nM, selectivity 28), the derivatives 20 and 21 are less potent, but highly selective (Ki 9.40 and 5.06 nM, selectivity 207 and 73, respectively).
Molecular Diversity | 2013
Mariarita Barone; Adriana Carol Eleonora Graziano; Agostino Marrazzo; Pietro Gemmellaro; Andrea Santagati; Venera Cardile
The aim of this work was to evaluate the potential anti-inflammatory activity of eleven (5–15) new synthesized derivatives of benzo-thieno[3,2-d]pyrimidine on two cell models, namely human keratinocytes NCTC 2544 and mouse monocyte-macrophages J774. For the synthesis of test compounds an efficient approach was developed: the key isothiocyanate was prepared through a simple and ecological method using di-2-pyridyl thionocarbonate (DPT) in substitution of thiophosgene, a highly toxic agent, and the cyclization reaction of benzo-thiosemicarbazide derivates was performed through Wamhoff methods. This procedure can be a new alternative method economically and environmentally advantageous by the simplicity of procedure, reduction of isolation and purification steps, time, costs, and waste production. The potential anti-inflammatory activity of 5–15 was evaluated by determining the expression of cyclooxygenase (COX)-2, inducible NO synthase (iNOS), and intercellular adhesion molecule-1 (ICAM-1), and the release of prostaglandins (PG)E
European Journal of Medicinal Chemistry | 2012
Livia Basile; Susana Álvarez; Almudena Blanco; Andrea Santagati; Giuseppe Granata; Patrizia Di Pietro; Salvatore Guccione; Ma Ángeles Muñoz-Fernández
Medicinal Chemistry | 2014
Mariarita Barone; Andrea Santagati; Adriana Carol Eleonora Graziano; Cosimo G. Fortuna; Giuseppe Ronsisvalle; Venera Cardile
_{2}
Molecules | 2014
Mariarita Barone; Giovanna Pannuzzo; Andrea Santagati; Alfio Catalfo; Guido De Guidi; Venera Cardile